Skip to main content
SpringerLink
Log in

Factor IX/prothrombin complex concentrates

Anaphylaxis in an infant: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Chuansumrit A, Moonsup Y, Sirachainan N, Benjaponpitak S, Suebsangad A, Wongwerawattanakoon P.The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate. Blood Coagulation and Fibrinolysis 19: 208-211, No. 3, Apr 2008 - Thailand

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Factor IX/prothrombin complex concentrates. React. Wkly. 1202, 15 (2008). https://doi.org/10.2165/00128415-200812020-00047

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812020-00047

Keywords

Search

Navigation